Evidence map›Paper›PMID 36441987›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

State Variation in Squamous Cell Carcinoma of the Anus Incidence and Mortality, and Association With HIV/AIDS and Smoking in the United States.

Haluk Damgacioglu, Yueh-Yun Lin, Ana Patricia Ortiz, Chi-Fang Wu, Zahed Shahmoradi, Shiang Shiuan Shyu, Ruosha Li, Alan G Nyitray, Keith Sigel, Gary M Clifford and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. 2024 Anal Cancer Screening Guidelines: Analysis of Clinical Performance and Use of High-Resolution Anoscopy in a Large Cohort of Persons With HIV.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

Haluk DamgaciogluCenter for Health Services Research, Department of Management, Policy, and Community Health, UTHealth School of Public Health, Houston, TX.ORCID 0000-0003-4361-4515
Yueh-Yun LinCenter for Health Services Research, Department of Management, Policy, and Community Health, UTHealth School of Public Health, Houston, TX.ORCID 0000-0001-9034-7718
Ana Patricia OrtizUniversity of Puerto Rico (UPR) Comprehensive Cancer Center, Division of Cancer Control and Population Sciences, San Juan, Puerto Rico.
Chi-Fang WuDepartment of Health Services Research, MD Anderson Cancer Center, Houston, TX.
Zahed ShahmoradiCenter for Health Services Research, Department of Management, Policy, and Community Health, UTHealth School of Public Health, Houston, TX.
Shiang Shiuan ShyuCenter for Health Services Research, Department of Management, Policy, and Community Health, UTHealth School of Public Health, Houston, TX.
Ruosha LiDepartment of Biostatistics and Data Science, UTHealth School of Public Health, Houston, TX.
Alan G NyitrayClinical Cancer Center, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0003-2020-9904
Keith SigelDepartment of General Internal Medicine, Department of Medicine, Mt Sinai Icahn School of Medicine, New York, NY.ORCID 0000-0002-4051-4861
Gary M CliffordEarly Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.ORCID 0000-0001-7534-333X
Naomi JayAnal Neoplasia Clinic, Research, and Education Center, University of California San Francisco, San Francisco, CA.
Vivian Colon LopezUniversity of Puerto Rico (UPR) Comprehensive Cancer Center, Division of Cancer Control and Population Sciences, San Juan, Puerto Rico.
Gregory M BarnellKaiser Permanente, Oakland Medical Center, Department of Surgery, Oakland, CA.ORCID 0000-0002-5453-5516
Elizabeth Y ChiaoDepartment of Epidemiology, MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-5752-2916
Elizabeth A StierDepartment of Obstetrics and Gynecology, Boston Medical Center/Boston University School of Medicine, Boston, MA.
Karen J Ortiz-OrtizUniversity of Puerto Rico (UPR) Comprehensive Cancer Center, Division of Cancer Control and Population Sciences, San Juan, Puerto Rico.ORCID 0000-0002-0134-9947
Jeslie M Ramos-CartagenaThe University of Puerto Rico/MD Anderson Cancer Center Partnership for Excellence in Cancer Research Program, San Juan, Puerto Rico.
Kalyani SonawaneDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC.
Ashish A DeshmukhDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC.ORCID 0000-0001-8936-8108
University of Texas Health Science Center at Dallas · USUniversity of Puerto Rico System · PRMedical University of South Carolina · USThe University of Texas MD Anderson Cancer Center · USBoston University · USCentre international de recherche sur le cancer · FRIcahn School of Medicine at Mount Sinai · USKaiser Permanente Oakland Medical Center · USMedical College of Wisconsin · USUniversity of California, San Francisco · US

Funding

UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297)U54CA096297 · NCI · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI Ilka C Rios · 2002 to 2026
$36.9M
UPR/MDACC Partnership for Excellence in Cancer Research (Luis Segarra supplement)U54CA096300 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Larkin Strong · 2002 to 2026
$23.8M
The Effectiveness of High Resolution Microendoscopy (HRME) in High Grade Intraepithelial Lesions (HSIL)Diagnosis for People Living with HIVR01CA232890 · NCI · BAYLOR COLLEGE OF MEDICINE · PI ANANDASABAPATHY, SHARMILA, CHIAO, ELIZABETH Y. · 2019 to 2025
$5.2M
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursorsR01CA256660 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHIAO, ELIZABETH Y., DESHMUKH, ASHISH A. · 2021 to 2025
$4.3M
Optimizing Age-based Anal Cancer Screening Among People Living with HIV using Decision Analytic ModelingR01CA232888 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DESHMUKH, ASHISH A. · 2019 to 2022
$2.0M
Harnessing Big Data to Identify Geographic Clusters of Low-income children with Poor HPV Vaccination RatesK01MD016440 · NIMHD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SONAWANE, KALYANI · 2021 to 2024
$464k
NCI NIH HHS R01 CA232888NCI NIH HHS R01 CA232890NCI NIH HHS R01 CA256660NCI NIH HHS U54 CA096297NCI NIH HHS U54 CA096300NIMHD NIH HHS K01 MD016440World Health Organization 001
6 · The paper itself

Abstract

purposeSquamous cell carcinoma of the anus (SCCA) incidence and mortality rates are rising in the United States. Understanding state-level incidence and mortality patterns and associations with smoking and AIDS prevalence (key risk factors) could help unravel disparities and provide etiologic clues.

methodsUsing the US Cancer Statistics and the National Center for Health Statistics data sets, we estimated state-level SCCA incidence and mortality rates. Rate ratios (RRs) were calculated to compare incidence and mortality in 2014-2018 versus 2001-2005. The correlations between SCCA incidence with current smoking (from the Behavioral Risk Factor Surveillance System) and AIDS (from the HIV Surveillance system) prevalence were evaluated using Spearman's rank correlation coefficient.

resultsNationally, SCCA incidence and mortality rates (per 100,000) increased among men (incidence, 2.29-3.36, mortality, 0.46-0.74) and women (incidence, 3.88-6.30, mortality, 0.65-1.02) age ≥ 50 years, but decreased among men age < 50 years and were stable among similar-aged women. In state-level analysis, a marked increase in incidence (≥ 1.5-fold for men and ≥ two-fold for women) and mortality (≥ two-fold) for persons age ≥ 50 years was largely concentrated in the Midwestern and Southeastern states. State-level SCCA incidence rates in recent years (2014-2018) among men were correlated (

conclusionDuring 2001-2005 to 2014-2018, SCCA incidence and mortality nearly doubled among men and women age ≥ 50 years living in Midwest and Southeast. State variation in AIDS and smoking patterns may explain variation in SCCA incidence. Improved and targeted prevention is needed to combat the rise in SCCA incidence and mitigate magnifying geographic disparities.

Indexed as

Acquired Immunodeficiency SyndromeAnus NeoplasmsCarcinoma, Squamous CellAgedAnal CanalFemaleHumansIncidenceMaleMiddle AgedSmokingUnited States

Identifiers

PMID36441987
PMCPMC9937095
OpenAlexW4310104205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.